经前期综合征和焦虑障碍

Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology. 2003;28:S25-S37.

• 摘要

World Health Organization. International statistical classification of diseases and related health problems, 10th Revision. N94.3 Premenstrual tension syndrome. 2nd ed. Geneva: WHO, 2007.

• 全文

Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome (Green-top guideline no. 48). December 2007. http://www.rcog.org.uk/ (last accessed 22 March 2016).

• 全文

Thangaratinam S, Ismail K, O'Brien S. Evidence-based management of premenstrual syndrome. Eur Clin Obstet Gynaecol. 2006;2:65-71.

Steiner M, Pearlstein T, Cohen LS, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006;15:57-69.

• 摘要

Ford O, Lethaby A, Roberts H, et al. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;(3):CD003415.

• 全文
• 摘要

Dimmock PW, Wyatt KM, Jones PW, et al. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet. 2000;356:1131-1136.

• 摘要

Wyatt KM, Dimmock PW, Ismail KM, et al. The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis. BJOG. 2004;111:585-593.

• 摘要

Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 2009;16:e407-e429.

• 摘要

1.  American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.

2.  Mortola JF. Issues in the diagnosis and research of premenstrual syndrome. Clin Obstet Gynecol. 1992;35:587-598.

• 摘要

3.  Steiner M, Born L. Diagnosis and treatment of premenstrual dysphoric disorder: an update. Int Clin Psychopharmacol 2000;15:S5-S17.

• 摘要

4.  Deuster PA, Adera T, South-Paul J. Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med. 1999;8:122-128.

• 摘要

5.  Mortola JF, Girton L, Beck L, et al. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol. 1990;76:302-307.

• 摘要

6.  Gallant SJ, Popiel DA, Hoffman DM, et al. Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations. Psychosom Med. 1992;54:149-166.

• 摘要

7.  O'Brien PM, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14:13-21.

• 摘要

8.  Budeiri DJ, Li Wan Po A, Dornan JC. Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynaecol. 1994;101:689-695.

• 摘要

9.  Monagle L, Dan A, Krogh V, et al. Perimenstrual symptom prevalence rates: an Italian-American comparison. Am J Epidemiol. 1993;138:1070-1081.

• 摘要

10.  Rupani NP, Lema VM. Premenstrual tension among nurses in Nairobi, Kenya. East Afr Med J. 1993;70:310-313.

• 摘要

11.  Sveinsdottir H, Marteinsdottir G. Retrospective assessment of premenstrual changes in Icelandic women. Health Care Women Int. 1991;12:303-315.

• 摘要

12.  Vichnin M, Freeman EW, Lin H, et al. Premenstrual syndrome (PMS) in adolescents: severity and impairment. J Pediatr Adolesc Gynecol. 2006;19:397-402.

• 摘要

13.  Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology. 2003;28:S25-S37.

• 摘要

14.  Steiner M, Romano SJ, Babcock S, et al. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder. BJOG. 2001;108:462-468.

• 摘要

15.  Kendler KS, Karkowski LM, Corey LA, et al. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry. 1998;155:1234-1240.

• 全文
• 摘要

16.  Beck LE, Gevirtz R, Mortola JF. The predictive role of psychosocial stress on symptom severity in premenstrual syndrome. Psychosom Med. 1990;52:536-543.

• 摘要

17.  Sassoon SA, Colrain IM, Baker FC. Personality disorders in women with severe premenstrual syndrome. Arch Womens Ment Health. 2011;14:257-264.

• 摘要

18.  Chocano-Bedoya PO, Manson JE, Hankinson SE, et al. Dietary B vitamin intake and incident premenstrual syndrome. Am J Clin Nutr. 2011;93:1080-1086.

• 摘要

19.  Wardlaw SL, Thoron L, Frantz AG. Effects of sex steroids on brain beta-endorphin. Brain Res. 1982;245:327-331.

• 摘要

20.  Chuong CJ, Hsi BP, Gibbons WE. Periovulatory beta-endorphin levels in premenstrual syndrome. Obstet Gynecol. 1994;83:755-760.

• 摘要

21.  Rojansky N, Halbreich U, Zander K, et al. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol Obstet Invest. 1991;31:146-152.

• 摘要

22.  Eriksson E, Alling C, Andersch B, et al. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Neuropsychopharmacology. 1994;11:201-213.

• 摘要

23.  Muse KN, Cetel NS, Futterman LA, et al. The premenstrual syndrome. Effects of "medical ovariectomy". N Engl J Med. 1984;311:1345-1349.

• 摘要

24.  Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod. 2004;19:2152-2155.

• 全文
• 摘要

25.  Bancroft J, Rennie D, Warner P. Vulnerability to perimenstrual mood change: the relevance of a past history of depressive disorder. Psychosom Med. 1994;56:225-231.

• 摘要

26.  Graze KK, Nee J, Endicott J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand. 1990;81:201-205.

• 摘要

27.  World Health Organization. International statistical classification of diseases and related health problems, 10th Revision. N94.3 Premenstrual tension syndrome. 2nd ed. Geneva: WHO, 2007.

• 全文

28.  Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome (Green-top guideline no. 48). December 2007. http://www.rcog.org.uk/ (last accessed 22 March 2016).

• 全文

29.  Lustyk MK, Gerrish WG, Shaver S, et al. Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2009;12:85-96.

• 摘要

30.  Thangaratinam S, Ismail K, O'Brien S. Evidence-based management of premenstrual syndrome. Eur Clin Obstet Gynaecol. 2006;2:65-71.

31.  Steiner M, Pearlstein T, Cohen LS, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006;15:57-69.

• 摘要

32.  Smith RN, Studd JW, Zamblera D, et al. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. Br J Obstet Gynaecol. 1995;102:475-484.

• 摘要

33.  Ford O, Lethaby A, Roberts H, et al. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;(3):CD003415.

• 全文
• 摘要

34.  Brown J, O'Brien PM, Marjoribanks J, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2009;(2):CD001396.

• 全文
• 摘要

35.  Dimmock PW, Wyatt KM, Jones PW, et al. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet. 2000;356:1131-1136.

• 摘要

36.  Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;(2):CD006586.

• 全文
• 摘要

37.  Parkin L, Sharples K, Hernandez RK, et al. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ. 2011;342:d2139.

• 全文
• 摘要

38.  Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ. 2011;342:d2151.

• 全文
• 摘要

39.  Halbreich U, Freeman EW, Rapkin AJ, et al. Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder. Contraception. 2012;85:19-27.

• 摘要

40.  Freeman EW, Rickels K, Sondheimer SJ, et al. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder. Am J Psychiatry. 2004;161:343-351.

• 全文
• 摘要

41.  Wyatt KM, Dimmock PW, Ismail KM, et al. The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis. BJOG. 2004;111:585-593.

• 摘要

42.  Jing Z, Yang X, Ismail KM, et al. Chinese herbal medicine for premenstrual syndrome. Cochrane Database Syst Rev. 2009;(1):CD006414.

• 全文
• 摘要

43.  Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 2009;16:e407-e429.

• 摘要

44.  Dante G, Facchinetti F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol. 2011;32:42-51.

• 摘要

45.  Shehata NA. Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: a double blind randomized placebo controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016;198:100-104.

• 摘要

46.  Ernst E, Posadzki P, Lee MS. Reflexology: an update of a systematic review of randomised clinical trials. Maturitas. 2011;68:116-120.

• 摘要

47.  Kim SY, Park HJ, Lee H, et al. Acupuncture for premenstrual syndrome: a systematic review and meta-analysis of randomised controlled trials. BJOG. 2011;118:899-915.

• 全文
• 摘要

48.  Leminen H, Heliovaara-Peippo S, Halmesmaki K, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on premenstrual symptoms in women treated for menorrhagia: secondary analysis of a randomized controlled trial. Acta Obstet Gynecol Scand. 2012;91:318-325.

• 摘要